SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-043646
Filing Date
2018-08-10
Accepted
2018-08-10 17:01:35
Documents
43
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv500043_10q.htm 10-Q 357178
2 EXHIBIT 31.1 tv500043_ex31-1.htm EX-31.1 8414
3 EXHIBIT 31.2 tv500043_ex31-2.htm EX-31.2 8465
4 EXHIBIT 32.1 tv500043_ex32-1.htm EX-32.1 3868
5 EXHIBIT 32.2 tv500043_ex32-2.htm EX-32.2 3868
12 GRAPHIC image_001.jpg GRAPHIC 3674
  Complete submission text file 0001144204-18-043646.txt   2030553

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ntrp-20180630.xml EX-101.INS 270665
7 XBRL TAXONOMY EXTENSION SCHEMA ntrp-20180630.xsd EX-101.SCH 21947
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ntrp-20180630_cal.xml EX-101.CAL 19957
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ntrp-20180630_def.xml EX-101.DEF 187114
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntrp-20180630_lab.xml EX-101.LAB 181448
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntrp-20180630_pre.xml EX-101.PRE 197623
Mailing Address 205 EAST 42ND STREET, 17TH FLOOR NEW YORK NY 10017
Business Address 205 EAST 42ND STREET, 17TH FLOOR NEW YORK NY 10017 (973) 242-0005
Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38045 | Film No.: 181009537
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1